Global Excellence 2020

Acquisition International - Global Excellence 2020 213 Acquisi International - Issu 7 2020 1 Mar20391 Planting the Seeds of the Future The world of healthcare is perpetually changing, with exciting new developments happening on an almost daily basis. The team at RYAH Medtech, Inc. is focused on collecting continuous anonymous patient data with a suite of IoT devices for plant based treatment and analysing gathered information with AI tools for its future use. Worthy winners of 2020’s Leading Plant-Based Technology Company - New York in Acquisition International’s Global Excellence Awards, we look more closely at this impressive company. lants have been the basis of new medical treatments for thousands of years, but the search to find new ways of exploiting them is still full of new avenues. RYAH Medtech has proven to be a game changer in reshaping our understanding of plant- based medicine. RYAH Medtech is bringing together exceptional data analytics, multiple dose-measuring delivery systems and proprietary software allows to power the cycle of plant based treatment from seed to consumption. The Company has developed a complete software and hardware platform that combines connected devices with its patented data analytics. The Company’s Smart IoT devices are designed to capture information on a wide range of data points including anonymous patient demographics, patient dosing, patient feedback, all cross- referenced with the plant medicine strain formulation. This solution enables researchers and clinics to test, validate, and register new ways of treatment and encourages development potentially breakthrough discoveries in plant based medicine. This remote patient and dosing solution is particularly relevant in this new paradigm of the global COVD-19 pandemic. Growers and dispensaries often use the anonymous, real-time patient consumption data from the RYAH Medtech devices to optimize strain recommendations, adapt their growing strategies and to better educate and match their products to the patients. With a patented Artificial Intelligence (AI) engine and multiple connected devices at the heart of the business, RYAH Medtech provides a complete turn-key solution for clinical trials and research institutions. The company has developed multiple, unique IoT delivery systems such as Smart Inhalers, Smart Patches and Smart Pens, combined with new, customized mobile applications that allow doctors and clinics to control the dose, set the temperature, record the effects, and review the statistics. The process of capturing strain data for each patient dose is, based on a QR code system which maintains the entire lab results of strains. Scanning the QR code on the sealed cartridge with the app - automatically links the medicine strain details to each dosing session and data point, eliminating data inaccuracies and illicit product entry. All of this valuable data is hosted on AWS HIPAA compliant cloud and backed by patented AI analytics technology to ensure the privacy and security. The future of clinical research heavily depends on continuous and accurate patient feedback that will enable trials to cross-analyse and process data more effectively, and with better results. Together with proprietary smart devices, RYAH Medtech offers customized software and applications designed to be convenient and easy to use for the patients, as well as highly effective and suitable for complex research P needs. RYAH Medtech devices are specifically designed to be agnostic to medicine type, meaning that cannabis and nutraceuticals, among other medicines, can be used in its products. The company has been granted the world’s first patent in Artificial Intelligence (AI) for data analytics in Cannabis, with six other patents pending on various IoT devices. In many ways, it is the ability of the firm to offer a complete, closed- loop ecosystem that sets it apart. Everything is interconnected, with focus on privacy and security. This approach has been key to reducing variability in clinical trials, and the firm is highly regarded by partners across the world. A forward-looking team of entrepreneurs that took RYAH Medtech to its achievements underlines the importance of being flexible with deep knowledge and a dynamic strategy, which has made RYAH Medtech a technological transformer compatible with various business models and partnerships. With the recent exciting secured partnerships, RYAH Medtech is planning to push even more technological advances. Over the next year, the plan is to fully marry the company’s captive connected device dosing data with its patented AI data analytics. This will provide a powerful, enterprise research solution for plant-based medicine. Alongside a slate of new connected devices, it will see the firm reach new heights in the field. In all, it’s little wonder that a company like RYAHMedtech has achieved such great work. The developments that the team have been working on are taking plant-based treatment to new data-focused approach powered by research and innovation. It’s this pioneering approach that has brought the company success so far, and seem set to push them into a bold and bright new future. 2020’s Leading Plant-Based Technology Company - New York